UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 26

Sortiert nach

Multidimensional single-cell analysis identifies a role for CD2-CD58 interactions in clinical antitumor T cell responses

The Journal of clinical investigation, 2022-09, Vol.132 (17), p.1-10

2022

Volltextzugriff (PDF)

Clinical‐Scale Derivation of Natural Killer Cells From Human Pluripotent Stem Cells for Cancer Therapy

Stem cells translational medicine, 2013-04, Vol.2 (4), p.274-283

2013

Volltextzugriff (PDF)

Regulated intratumoral expression of IL-12 using a RheoSwitch Therapeutic System ® (RTS ® ) gene switch as gene therapy for the treatment of glioma

Cancer gene therapy, 2018-06, Vol.25 (5-6), p.106-116

2018

Volltextzugriff (PDF)

Visualizing fewer than 10 mouse T cells with an enhanced firefly luciferase in immunocompetent mouse models of cancer

Proceedings of the National Academy of Sciences - PNAS, 2008-09, Vol.105 (38), p.14342-14346

2008

Volltextzugriff (PDF)

Tethered IL-15 augments antitumor activity and promotes a stem-cell memory subset in tumor-specific T cells

Proceedings of the National Academy of Sciences - PNAS, 2016-11, Vol.113 (48), p.E7788-E7797

2016

Volltextzugriff (PDF)

Regulatable interleukin-12 gene therapy in patients with recurrent high-grade glioma: Results of a phase 1 trial

Science translational medicine, 2019-08, Vol.11 (505)

2019

Volltextzugriff (PDF)

Membrane-bound IL-21 promotes sustained ex vivo proliferation of human natural killer cells

PloS one, 2012-01, Vol.7 (1), p.e30264-e30264

2012

Volltextzugriff (PDF)

A Transposon and Transposase System for Human Application

Molecular therapy, 2010-04, Vol.18 (4), p.674-683

2010

Volltextzugriff (PDF)

Amplification of RNAi—Targeting HLA mRNAs

Molecular therapy, 2005-05, Vol.11 (5), p.811-818

2005

Volltextzugriff (PDF)

Bioengineering T cells to target carbohydrate to treat opportunistic fungal infection

Proceedings of the National Academy of Sciences - PNAS, 2014-07, Vol.111 (29), p.10660-10665

2014

Volltextzugriff (PDF)

Preclinical Efficacy and Safety of CD19CAR Cytokine-Induced Killer Cells Transfected with Sleeping Beauty Transposon for the Treatment of Acute Lymphoblastic Leukemia

Human gene therapy, 2018-05, Vol.29 (5), p.602

2018

Volltextzugriff (PDF)

Chimeric antigen receptor (CAR)-specific monoclonal antibody to detect CD19-specific T cells in clinical trials

PloS one, 2013-03, Vol.8 (3), p.e57838-e57838

2013

Volltextzugriff (PDF)

Manufacture of clinical-grade CD19-specific T cells stably expressing chimeric antigen receptor using Sleeping Beauty system and artificial antigen presenting cells

PloS one, 2013-05, Vol.8 (5), p.e64138-e64138

2013

Volltextzugriff (PDF)

Cytotoxic T lymphocytes targeting a conserved SARS-CoV-2 spike epitope are efficient serial killers

BioTechniques, 2022-04, Vol.72 (4), p.113-120

2022

Volltextzugriff (PDF)

Redirecting Specificity of T cells Using the Sleeping Beauty System to Express Chimeric Antigen Receptors by Mix-and-Matching of VL and VH Domains Targeting CD123+ Tumors

PloS one, 2016-08, Vol.11 (8), p.e0159477-e0159477

2016

Volltextzugriff (PDF)

Very rapid cloning, expression and identifying specificity of T-cell receptors for T-cell engineering

PloS one, 2020-02, Vol.15 (2), p.e0228112-e0228112

2020

Volltextzugriff (PDF)

Stable, Nonviral Expression of Mutated Tumor Neoantigen-specific T-cell Receptors Using the Sleeping Beauty Transposon/Transposase System

Molecular therapy, 2016-06, Vol.24 (6), p.1078-1089

2016

Volltextzugriff (PDF)

Delayed immune reconstitution after cord blood transplantation is characterized by impaired thymopoiesis and late memory T-cell skewing

Blood, 2007-12, Vol.110 (13), p.4543-4551

2007

Volltextzugriff (PDF)

Aurora kinase inhibition sensitizes melanoma cells to T-cell-mediated cytotoxicity

Cancer Immunology, Immunotherapy, 2021-04, Vol.70 (4), p.1101-1113

2021

Volltextzugriff (PDF)

T cells expressing CD19-specific Engager Molecules for the Immunotherapy of CD19-positive Malignancies

Scientific reports, 2016-06, Vol.6 (1), p.27130-27130, Article 27130

2016

Volltextzugriff (PDF)

Sleeping Beauty Transposition of Chimeric Antigen Receptors Targeting Receptor Tyrosine Kinase-Like Orphan Receptor-1 (ROR1) into Diverse Memory T-Cell Populations

PloS one, 2015-06, Vol.10 (6), p.e0128151-e0128151

2015

Volltextzugriff (PDF)

CARs on Track in the Clinic

Molecular therapy, 2011-03, Vol.19 (3), p.432-438

2011

Volltextzugriff (PDF)

Adoptive T-cell therapy improves treatment of canine non-Hodgkin lymphoma post chemotherapy

Scientific reports, 2012-02, Vol.2 (1), p.249, Article 249

2012

Volltextzugriff (PDF)

Designed improvement to T-cell immunotherapy by multidimensional single cell profiling

Journal for immunotherapy of cancer, 2021-03, Vol.9 (3), p.e001877

2021

Volltextzugriff (PDF)

1 – 25 von 26

Suche als RSS-Feed

Aktive Filter

ThemaLymphocytes

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(26)
Mit Volltextzugriff
(24)

Publikationsform

Artikel
(26)

Sprache

Englisch
(26)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

Science & Technology
(26)
Humans
(21)
Animals
(16)
Antigens
(15)
Immunotherapy
(15)
Life Sciences & Biomedicine
(15)
Mice
(15)
T-Lymphocytes - Immunology
(14)
Cancer
(11)
Multidisciplinary Sciences
(11)
Science & Technology - Other Topics
(11)
Gene Expression
(10)
Leukemia
(10)
Medicine, Research & Experimental
(10)
Research & Experimental Medicine
(10)
T Cell Receptors
(10)
Clinical Trials
(9)
Cytokines
(9)
Lymphocytes T
(9)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Multidimensional single-cell analysis identifies a role for CD2-CD58 interactions in clinical antitumor T cell responses

Clinical‐Scale Derivation of Natural Killer Cells From Human Pluripotent Stem Cells for Cancer Therapy

Regulated intratumoral expression of IL-12 using a RheoSwitch Therapeutic System ® (RTS ® ) gene switch as gene therapy for the treatment of glioma

Visualizing fewer than 10 mouse T cells with an enhanced firefly luciferase in immunocompetent mouse models of cancer

Tethered IL-15 augments antitumor activity and promotes a stem-cell memory subset in tumor-specific T cells

Regulatable interleukin-12 gene therapy in patients with recurrent high-grade glioma: Results of a phase 1 trial

Phase I trials using Sleeping Beauty to generate CD19-specific CAR T cells

Membrane-bound IL-21 promotes sustained ex vivo proliferation of human natural killer cells

A Transposon and Transposase System for Human Application

Amplification of RNAi—Targeting HLA mRNAs

Bioengineering T cells to target carbohydrate to treat opportunistic fungal infection

Preclinical Efficacy and Safety of CD19CAR Cytokine-Induced Killer Cells Transfected with Sleeping Beauty Transposon for the Treatment of Acute Lymphoblastic Leukemia

Chimeric antigen receptor (CAR)-specific monoclonal antibody to detect CD19-specific T cells in clinical trials

Manufacture of clinical-grade CD19-specific T cells stably expressing chimeric antigen receptor using Sleeping Beauty system and artificial antigen presenting cells

Cytotoxic T lymphocytes targeting a conserved SARS-CoV-2 spike epitope are efficient serial killers

Redirecting Specificity of T cells Using the Sleeping Beauty System to Express Chimeric Antigen Receptors by Mix-and-Matching of VL and VH Domains Targeting CD123+ Tumors

Very rapid cloning, expression and identifying specificity of T-cell receptors for T-cell engineering

Stable, Nonviral Expression of Mutated Tumor Neoantigen-specific T-cell Receptors Using the Sleeping Beauty Transposon/Transposase System

Delayed immune reconstitution after cord blood transplantation is characterized by impaired thymopoiesis and late memory T-cell skewing

Aurora kinase inhibition sensitizes melanoma cells to T-cell-mediated cytotoxicity

T cells expressing CD19-specific Engager Molecules for the Immunotherapy of CD19-positive Malignancies

Sleeping Beauty Transposition of Chimeric Antigen Receptors Targeting Receptor Tyrosine Kinase-Like Orphan Receptor-1 (ROR1) into Diverse Memory T-Cell Populations

CARs on Track in the Clinic

Adoptive T-cell therapy improves treatment of canine non-Hodgkin lymphoma post chemotherapy

Designed improvement to T-cell immunotherapy by multidimensional single cell profiling

Aktive Filter

Suchergebnisse filtern